Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

As The Hive Evolves, More Companies Prepare to Join the Program

Posted on December 11th, 2017 by in Pharma R&D

This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive Continue reading “As The Hive Evolves, More Companies Prepare to Join the Program” »

Selecting Anti-Melanoma Drug Targets

Posted on August 28th, 2017 by in Pharma R&D

Every year, hundreds of thousands of people are diagnosed with melanoma, the most deadly form of skin cancer. Although rates of melanoma have continued to rise over the last three decades Continue reading “Selecting Anti-Melanoma Drug Targets” »

Cancer Immunotherapy Webinar on September 12: Register Now

Posted on August 25th, 2017 by in Pharma R&D

After decades of being treated with a fairly typical combination of surgery and therapies, cancer is now being met with exciting new treatments that are more targeted and often less hard on the patient. Continue reading “Cancer Immunotherapy Webinar on September 12: Register Now” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

  1. 1
  2. 2